Two from Duke Selected for 2018-2019 ELAM Program

Friday, April 13, 2018

Congratulations to Shelley Hwang, MD, MPH, and Sallie Permar, MD, PhD, on their selection as 2018-2019 fellows of the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women. ELAM is a prestigious national fellowship that aims to increase and sustain the number and impact of women in academic leadership positions in the health sciences. The intensive one-year program includes executive education, coaching, networking and mentoring in strategic finance and resource management, personal and professional leadership effectiveness, organizational dynamics, and communities of leadership practice.

Selection to the program is highly competitive and each institution is limited in the number of applicants they can put forward. There is both an internal and an external selection process for ELAM. Eligible candidates include women faculty at the associate or full professor level.  The call for applications comes out in the early fall. Applying for ELAM involves considerable prep work, so faculty interested in pursuing this opportunity in future years should notify Vice Dean for Faculty Ann Brown of their interest soon and begin conversations with their chair in the spring and early summer.

Learn more about ELAM 

About the scholars:



Shelley Hwang, MD, MPH is Professor of Surgery and Radiology, Vice Chair for Research in the Department of Surgery, and Section Chief of Breast Surgery at the Duke Cancer Institute. Her research focuses on informed approaches to treatment of ductal carcinoma in situ (DCIS). 





Sallie Permar, MD, PhD, is Professor of Pediatrics, Molecular Genetics and Microbiology, and Immunology, an affiliate of the Duke Global Health Institute, an associate of the Duke Initiative for Science and Society, a member of the Duke Human Vaccine Institute, and Director of the Children’s Health and Discovery Initiative within the Department of Pediatrics and Translating Duke Health. Her research focuses on the development of vaccines to prevent vertical transmission of neonatal viral pathogens.



Congratulations to Dr. Hwang and Dr. Permar on this outstanding accomplishment!